No. | Sex | Age | Diagnosis | NYHA class | Symptoms | MVo2 (%) | RAP (mmHg) | Cardiac index (l/min/m2) | mPAP (mmHg) | PVR index (WU.m2) | NIH probability of surviving 2 years | 02 saturation before | 02 saturation after | Size of largest balloon | Procedure | Syncope relieved | Repeat procedure |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NIH probability refers to the likelihood of surviving 2 years from the date of the right heart catheter based on the regression equation from D’Alonzo et al1 using haemodynamic parameters. | |||||||||||||||||
MVo2, mixed venous oxygen saturation; NA, not available; NYHA, New York Heart Association; mPAP, mean pulmonary artery pressure, PPH, primary pulmonary hypertension; PVR, pulmonary vascular resistance; RAP, right atrial pressure; SSc, scleroderma. | |||||||||||||||||
1 | F | 33.5 | PPH | III | Pre-syncope | NA | 13 | 1.56 | 67 | 37.2 | 0.45 | 94 | 89 | 15 | Uneventful | Yes | At 15 months hole reopened |
2 | F | 57.0 | SSc | IV | Syncope | 60.2 | 16 | 1.34 | 59 | 37.2 | 0.42 | 93 | 91 | 18 | Uneventful | Yes | No |
3 | F | 72.3 | PPH | IV | Pre-syncope | NA | 24 | 1.51 | 50 | 24.6 | 0.37 | 95 | 87 | 15 | Uneventful | Yes | At 4 months hole enlarged to 20 mm |
4 | F | 68.8 | PPH | IV | Syncope | 67 | 12 | 1.76 | 56 | 28.4 | 0.50 | 97 | 78 | 12 | Thyrotoxic at time of procedure | Yes | No |
5 | F | 25.9 | PPH | III | Syncope | 65 | 5 | 1.82 | 51 | 24.7 | 0.61 | 99 | 85 | 12 | BP dropped for procedure. Transfused 2 units | Yes | At 3 months hole enlarged to 18 mm |
6 | F | 24.5 | PPH | III | Pre-syncope | 55 | 8 | 1.43 | 53 | 34.2 | 0.53 | 97 | 84 | 18 | Uneventful | Yes | No |
7 | F | 76.3 | SSc | IV | Pre-syncope | 61 | 7 | 1.49 | 37 | 20.2 | 0.59 | 98 | 93 | 18 | Uneventful | Yes | No |
8 | F | 80.2 | SSc | IV | Syncope | 62 | 8 | 1.82 | 55 | 25.8 | 0.55 | 95 | 91 | 18 | Transfused pre-procedure. Uneventful | Yes | No |
9 | F | 69.2 | PPH | IV | Syncope | 59 | 6 | 1.44 | 53 | 31.3 | 0.56 | 96 | 87 | 12 | Uneventful | Yes | No |